⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1862724 | 1.00 | — | — | |
| SCHEMBL868250 | 1.00 | — | — | |
| SCHEMBL5204413 | 1.00 | — | — | |
| SCHEMBL63344 | 1.00 | — | — | |
| SCHEMBL2574001 | 0.82 | — | — | |
| Water SCHEMBL3683194 | 0.82 | — | — | |
| SCHEMBL820038 | 0.82 | — | — | |
| SCHEMBL6913370 | 0.82 | — | — | |
| Water SCHEMBL2127946 | 0.82 | — | — | |
| SCHEMBL5961161 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736321-A2 | HIGH-SPEED, HIGH-POWER OPERATIONAL AMPLIFIER AND LINEAR AMPLITUDE MODULATOR | Eridan Communications d.o.o. (HR) | 2026-05-06 | — | — | EP | disclosed |
| US-20250375517-A1 | PEANUT FORMULATIONS AND USES THEREOF | NESTLE SA (CH) | 2025-12-11 | — | — | US | disclosed |
| EP-4522133-A1 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | Poviva Corp. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-4522159-A1 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | Poviva Corp. (US) | 2025-03-19 | — | — | EP | disclosed |
| EP-4518846-A1 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | Poviva Corp. (US) | 2025-03-12 | — | — | EP | disclosed |
| WO-2025024009-A1 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | Poviva Corp. (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2025024007-A1 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | POVIVA CORP . (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2025006019-A2 | HIGH-SPEED, HIGH-POWER OPERATIONAL AMPLIFIER AND LINEAR AMPLITUDE MODULATOR | ERIDAN COMMUNICATIONS, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024182756-A2 | CELL-SPECIFIC CIS-REGULATORY ELEMENTS, USES THEREOF, AND METHODS OF GENERATING THE SAME | THE BROAD INSTITUTE, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| US-12016917-B2 | Peanut formulations and uses thereof | Société des Produits Nestlé S.A. (CH) | 2024-06-25 | — | — | US | disclosed |
| WO-2024092238-A1 | KLOTHO POLYPEPTIDE OR POLYNUCLEOTIDE FOR IMPROVING COGNITION | UNITY BIOTECHNOLOGY, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-115768790-A | Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | 范德比尔特大学 | 2023-03-07 | — | — | CN | disclosed |
| WO-2023011723-A1 | IDENTIFICATION OF SOMATIC VARIANTS | GENOME RESEARCH LIMITED (GB) | 2023-02-09 | — | — | WO | disclosed |
| CN-115083945-A | Apparatus and method for assisted release of microelectronic devices from a carrier structure energy field | 美光科技公司 | 2022-09-20 | — | — | CN | disclosed |